New Zealand markets closed
  • NZX 50

    11,682.56
    -45.91 (-0.39%)
     
  • NZD/USD

    0.6245
    +0.0005 (+0.07%)
     
  • NZD/EUR

    0.6130
    +0.0009 (+0.14%)
     
  • ALL ORDS

    7,250.70
    +0.40 (+0.01%)
     
  • ASX 200

    7,014.10
    -1.50 (-0.02%)
     
  • OIL

    89.19
    +0.18 (+0.20%)
     
  • GOLD

    1,787.50
    -3.70 (-0.21%)
     
  • NASDAQ

    13,207.69
    -103.31 (-0.78%)
     
  • FTSE

    7,439.74
    -8.32 (-0.11%)
     
  • Dow Jones

    32,803.47
    +76.67 (+0.23%)
     
  • DAX

    13,573.93
    -88.77 (-0.65%)
     
  • Hang Seng

    20,050.15
    -151.79 (-0.75%)
     
  • NIKKEI 225

    28,252.54
    +76.67 (+0.27%)
     
  • NZD/JPY

    84.4250
    +0.2190 (+0.26%)
     

Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors

·1-min read

DEERFIELD, Ill., June 08, 2022--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2022 financial results on Thursday, July 28, 2022 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/EmxweYhQ to pre-register for the call and receive the call information.

This call is also being webcast and can be accessed through Baxter’s website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter’s permission.

About Baxter

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220608005839/en/

Contacts

Media Contact
Eric Tatro, (224) 948-5353
media@baxter.com

Investor Contact
Clare Trachtman, (224) 948-3020

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting